Tag: China approval

Vunakizumab Approved in China for Moderate-to-Severe Plaque Psoriasis

October 28, 2026

Vunakizumab, a new anti-IL-17A monoclonal antibody, is approved in China for adults with moderate-to-severe chronic plaque psoriasis after phase 3 ...

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Multi-omics study maps how crossbreeding shapes fat and flavor in rabbit meat

DNA hydroxymethylation shifts in the striatum tracked across stages in a Parkinson’s mouse model

Chronic D-serine at 200 mg/kg shows kidney toxicity signs in Parkinson’s disease rats

Subscribe to Blog via Email

Join 85 other subscribers

No Result

View All Result

Tag: China approval

Vunakizumab Approved in China for Moderate-to-Severe Plaque Psoriasis

POPULAR NEWS

Machine learning digital twin predicts electric powertrain efficiency in real time

Photon-counting CT outperforms dual-energy scanners at detecting tiny iodine traces

Gut microbiome shifts in fibromyalgia track symptom severity, study finds

Ball milling tunes nickel–ceria interfaces for cleaner methane reforming

About

Follow us

Recent News

Multi-omics study maps how crossbreeding shapes fat and flavor in rabbit meat

DNA hydroxymethylation shifts in the striatum tracked across stages in a Parkinson’s mouse model

Chronic D-serine at 200 mg/kg shows kidney toxicity signs in Parkinson’s disease rats

Subscribe to Blog via Email

Welcome Back!

Retrieve your password